{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/B",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "BLOOD AND BLOOD FORMING ORGANS" , "@language" : "en" } ,        { "@value" : "Krev a krvetvorn\u00E9 org\u00E1ny" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "B" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/B01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Antikoagulancia, antitrombotika" , "@language" : "cs" } ,        { "@value" : "ANTITHROMBOTIC AGENTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "B01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/B01A",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Antikoagulancia, antitrombotika" , "@language" : "cs" } ,        { "@value" : "ANTITHROMBOTIC AGENTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "B01A" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/B01AC",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Antiagregancia krom\u011B heparinu" , "@language" : "cs" } ,        { "@value" : "Platelet aggregation inhibitors excl. heparin" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "B01AC" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/B01AC09",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/B" ,        "http://linked.opendata.cz/resource/ATC/B01" ,        "http://linked.opendata.cz/resource/ATC/B01A" ,        "http://linked.opendata.cz/resource/ATC/B01AC" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Epoprostenol" , "@language" : "cs" } ,        { "@value" : "Epoprostenol" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "B01AC09" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0017819",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Epoprostenol sodium" , "@language" : "cs" } ,        { "@value" : "Epoprostenol sodium" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPharmacologicalAction" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0017012" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/B" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/FLOLAN-1-5-MG",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0017819" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "FLOLAN 1,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/B01AC09" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/B" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0020913" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0020912" ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Antihypertenz\u00EDva" , "@language" : "cs" } ,        { "@value" : "Antihypertensive agents" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0017012",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Inhibitory agregace trombocyt\u016F" , "@language" : "cs" } ,        { "@value" : "Platelet aggregation inhibitors" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0020913",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "FLOLAN 1,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/B01AC09" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VASODILATANTIA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC161946_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "1+2X50ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Infuze" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "15RG/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Flolan je indikov\u00E1n k l\u00E9\u010Db\u011B:\nPlicn\u00ED arteri\u00E1ln\u00ED hypertenze\nFlolan je indikov\u00E1n k l\u00E9\u010Db\u011B pacient\u016F s plicn\u00ED arteri\u00E1ln\u00ED hypertenz\u00ED (PAH) (idiopatick\u00E1 nebo d\u011Bdi\u010Dn\u00E1 PAH a PAH spojen\u00E1 s\u00A0onemocn\u011Bn\u00EDm pojivov\u00FDch tk\u00E1n\u00ED) u pacient\u016F se symptomy III-IV funk\u010Dn\u00ED t\u0159\u00EDdy podle WHO ke zlep\u0161en\u00ED z\u00E1t\u011B\u017Eov\u00E9 kapacity (viz bod 5.1).  \nHemodial\u00FDza\nP\u0159\u00EDpravek Flolan je indikov\u00E1n k\u00A0u\u017Eit\u00ED p\u0159i hemodial\u00FDze v\u00A0akutn\u00EDch p\u0159\u00EDpadech, kdy pod\u00E1n\u00ED heparinu p\u0159edstavuje vysok\u00E9 riziko krv\u00E1cen\u00ED nebo jeho exacerbace, nebo pokud je pod\u00E1n\u00ED heparinu kontraindikov\u00E1no z jin\u00FDch d\u016Fvod\u016F (viz bod 5.1). \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 6907.83984375 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 6464.35986328125 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INF PSO LQF 1X1.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0020912",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "FLOLAN 1,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/B01AC09" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VASODILATANTIA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC161946_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "1+1X50ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Infuze" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "30RG/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Flolan je indikov\u00E1n k l\u00E9\u010Db\u011B:\nPlicn\u00ED arteri\u00E1ln\u00ED hypertenze\nFlolan je indikov\u00E1n k l\u00E9\u010Db\u011B pacient\u016F s plicn\u00ED arteri\u00E1ln\u00ED hypertenz\u00ED (PAH) (idiopatick\u00E1 nebo d\u011Bdi\u010Dn\u00E1 PAH a PAH spojen\u00E1 s\u00A0onemocn\u011Bn\u00EDm pojivov\u00FDch tk\u00E1n\u00ED) u pacient\u016F se symptomy III-IV funk\u010Dn\u00ED t\u0159\u00EDdy podle WHO ke zlep\u0161en\u00ED z\u00E1t\u011B\u017Eov\u00E9 kapacity (viz bod 5.1).  \nHemodial\u00FDza\nP\u0159\u00EDpravek Flolan je indikov\u00E1n k\u00A0u\u017Eit\u00ED p\u0159i hemodial\u00FDze v\u00A0akutn\u00EDch p\u0159\u00EDpadech, kdy pod\u00E1n\u00ED heparinu p\u0159edstavuje vysok\u00E9 riziko krv\u00E1cen\u00ED nebo jeho exacerbace, nebo pokud je pod\u00E1n\u00ED heparinu kontraindikov\u00E1no z jin\u00FDch d\u016Fvod\u016F (viz bod 5.1). \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 3020.889892578125 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 6464.35986328125 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INF PSO LQF 1X1.5MG" , "@language" : "cs" } ] }] }